World

US FDA panel to vote on data, safety profile of Lilly Alzheimer’s drug

2024.06.06 10:24

(Reuters) -A panel of outside experts to the U.S. health regulator will meet on Monday to vote on safety and efficacy data for Lilly’s (N:) donanemab, a potential rival to Eisai and Biogen (NASDAQ:)’s Leqembi, and make recommendations to the FDA.

Both the drugs are antibodies designed to remove toxic beta amyloid plaques from the brains of people with early Alzheimer’s disease.

The panel will also vote on whether benefits of the treatment outweigh its risks, documents published on the agency’s website on Thursday showed.

Its recommendations are non-binding but typically followed by the U.S. Food and Drug Administration.

Staff advisers to the health regulator recommended that if Lilly’s donanemab is approved, then certain risk factors such as brain bleeding should be identified in the prescribing information.

Reviewers said certain post-approval requirements may be requested, including expedited reporting of any deaths in ongoing studies of donanemab.

Drugs like donanemab and Leqembi, which are designed to slow disease progression in early-stage patients, represent a new era in the treatment of Alzheimer’s, after three decades of failed attempts to fight the fatal disease.

© Reuters. FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo

More than 6 million Americans have some form of the mind-wasting condition, according to the Alzheimer’s Association.

Alzheimer’s trials have previously found safety concerns such as brain swelling and bleeding associated with this class of drugs. In Lilly’s trial, three participants died from complications linked to the treatment.



Source link

Related Articles

Back to top button
bitcoin
Bitcoin (BTC) $ 98,175.30 5.43%
ethereum
Ethereum (ETH) $ 3,494.95 6.69%
tether
Tether (USDT) $ 1.00 0.19%
xrp
XRP (XRP) $ 2.32 8.65%
bnb
BNB (BNB) $ 696.61 3.98%
solana
Solana (SOL) $ 198.37 9.41%
dogecoin
Dogecoin (DOGE) $ 0.336882 10.80%
usd-coin
USDC (USDC) $ 1.00 0.21%
cardano
Cardano (ADA) $ 0.944553 9.35%
staked-ether
Lido Staked Ether (STETH) $ 3,492.55 6.67%
tron
TRON (TRX) $ 0.258425 4.52%
avalanche-2
Avalanche (AVAX) $ 40.90 14.32%
chainlink
Chainlink (LINK) $ 24.70 11.45%
the-open-network
Toncoin (TON) $ 5.77 7.27%
wrapped-steth
Wrapped stETH (WSTETH) $ 4,128.33 5.99%
shiba-inu
Shiba Inu (SHIB) $ 0.000023 10.18%
sui
Sui (SUI) $ 4.62 11.93%
wrapped-bitcoin
Wrapped Bitcoin (WBTC) $ 97,739.19 5.13%
hedera-hashgraph
Hedera (HBAR) $ 0.32088 21.60%
stellar
Stellar (XLM) $ 0.397438 13.95%
polkadot
Polkadot (DOT) $ 7.58 10.55%
hyperliquid
Hyperliquid (HYPE) $ 30.18 14.21%
weth
WETH (WETH) $ 3,496.73 6.86%
bitcoin-cash
Bitcoin Cash (BCH) $ 476.87 10.27%
uniswap
Uniswap (UNI) $ 14.62 8.32%
leo-token
LEO Token (LEO) $ 9.44 0.53%
litecoin
Litecoin (LTC) $ 110.50 10.93%
pepe
Pepe (PEPE) $ 0.000019 10.87%
bitget-token
Bitget Token (BGB) $ 4.94 22.40%
wrapped-eeth
Wrapped eETH (WEETH) $ 3,691.39 6.73%
near
NEAR Protocol (NEAR) $ 5.62 12.31%
ethena-usde
Ethena USDe (USDE) $ 0.999856 0.20%
aave
Aave (AAVE) $ 377.54 13.43%
aptos
Aptos (APT) $ 9.86 9.65%
internet-computer
Internet Computer (ICP) $ 11.18 12.88%
usds
USDS (USDS) $ 1.00 0.35%
crypto-com-chain
Cronos (CRO) $ 0.166715 9.30%
polygon-ecosystem-token
POL (ex-MATIC) (POL) $ 0.531999 13.63%
vechain
VeChain (VET) $ 0.053385 18.74%
ethereum-classic
Ethereum Classic (ETC) $ 28.26 9.11%
mantle
Mantle (MNT) $ 1.24 7.49%
render-token
Render (RENDER) $ 7.95 14.68%
bittensor
Bittensor (TAO) $ 503.05 13.13%
fetch-ai
Artificial Superintelligence Alliance (FET) $ 1.42 13.10%
mantra-dao
MANTRA (OM) $ 3.81 9.27%
monero
Monero (XMR) $ 192.66 1.30%
whitebit
WhiteBIT Coin (WBT) $ 24.67 1.40%
arbitrum
Arbitrum (ARB) $ 0.831268 10.90%
dai
Dai (DAI) $ 1.00 0.18%
algorand
Algorand (ALGO) $ 0.405112 16.18%